95440-99-6

Basic information

• Product Name: (17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one
• CAS NO: 95440-99-6
• Molecular Formula: C₂₃H₃₂N₂OS
• Molecular Weight: 384.578
• Mol File: 95440-99-6.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 534.2°C at 760 mmHg
• Flash Point: 276.9°C
• Density: 1.18g/cm³
• Vapor Pressure: 1.73E-11mmHg at 25°C
• Refractive Index: 1.595
• CAS DataBase Reference: (17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: (17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one(95440-99-6)
• EPA Substance Registry System: (17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one(95440-99-6)

Safety Data

• Hazardous Substances Data: 95440-99-6(Hazardous Substances Data)

Usage

Description

(17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one is a synthetic chemical compound that belongs to the class of androgens, which are a group of steroid hormones that provide masculinizing effects in the body. This specific compound is a derivative of testosterone, with a methylamino-thiazolyl group attached to the C17beta position. It is primarily used in scientific research and drug development for its potential anabolic and androgenic properties.
Used in Scientific Research:
(17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one is used as a research compound for studying the effects of androgens on the body and their potential applications in medicine.
Used in Drug Development:
(17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one is used as a lead compound in the development of new pharmaceuticals targeting anabolic and androgenic pathways for the treatment of various medical conditions.
Used in Medical Treatments:
(17beta)-17-[2-(methylamino)-1,3-thiazol-4-yl]androst-4-en-3-one has the potential to be used as a therapeutic agent for treating certain medical conditions that may benefit from its anabolic and androgenic properties, such as muscle wasting diseases or hormonal imbalances. However, further research and clinical trials are required to establish its safety and efficacy in these applications.

Upstream product

• 20576-46-9 11-deoxy-21-iodocorticosterone 
• 598-52-7 1-(methyl)-thiourea